文献速递头颈外科

术前确诊与未确诊的大涎腺癌:临床病理特征、治疗策略及肿瘤学结局比较

Preoperatively Diagnosed Versus Undiagnosed Major Salivary Gland Cancer: Clinicopathological Characteristics, Treatment Strategies, and Oncological Outcomes.
PubMed 文献 · Otolaryngol Head Neck Surg · 2026-07-06

该回顾性队列研究纳入2012至2023年经手术证实的大涎腺癌122例,按术前是否通过细针穿刺细胞学或空心针活检确诊分为确诊组49例(40.2%)和未确诊组73例(59.8%)。未确诊组更依赖细针穿刺细胞学、低/中级别肿瘤和黏液表皮样癌比例更高,手术延迟且范围更局限;高级别或晚期未确诊者局部区域控制有更差趋势。

要点

  • 术前未确诊的大涎腺癌更常见低/中级别和黏液表皮样癌。
  • 未确诊组手术延迟更久且全腮腺切除和择区颈清扫比例更低。
  • 高级别或晚期未确诊者局部区域控制有更差趋势。

核心结论

  • 术前未确诊的大涎腺癌在临床病理特征、治疗策略和肿瘤学结局上与术前确诊者不同,凸显术前诊断的重要性。

研究设计与样本

  • 单中心三级学术医院2012至2023年经手术证实的大涎腺癌回顾性队列研究,共122例。

主要发现

  • 未确诊组更依赖细针穿刺细胞学(93.2% vs 51.0%,P < .001),低/中级别肿瘤比例更高(75% vs 26.5%,P < .001),黏液表皮样癌比例更高(45.2% vs 18.4%,P < .001)。
  • 多因素logistic回归分析证实上述因素为术前未确诊的独立危险因素。
  • 未确诊组手术延迟更久(60 vs 24天,P < .001),近全/全腮腺切除频率更低(23.3% vs 42.9%,P = .001),择区颈清扫比例更低(26.5% vs 61.6%,P < .001)。
  • 按级别和分期匹配分析显示,高级别或晚期未确诊大涎腺癌的局部区域控制有更差趋势。

关键数值与推荐

  • 术前诊断依据细针穿刺细胞学或空心针活检确定大涎腺癌。
  • 未确诊组细针穿刺细胞学使用率93.2%,确诊组51.0%(P < .001)。
  • 未确诊组低/中级别肿瘤占75%,确诊组26.5%(P < .001)。
  • 未确诊组黏液表皮样癌占45.2%,确诊组18.4%(P < .001)。
  • 未确诊组手术延迟60天,确诊组24天(P < .001)。

临床怎么用

  • 对大涎腺肿瘤应重视术前细针穿刺细胞学或空心针活检以明确诊断。
  • 术前未确诊者需警惕手术范围不足和延迟,尤其高级别或晚期病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate differences in clinicopathological characteristics, treatment strategies, and oncological outcomes between preoperatively diagnosed and undiagnosed major salivary gland cancers (MSGCs). STUDY DESIGN: Retrospective cohort study. SETTING: A single tertiary academic hospital. METHODS: Surgically confirmed MSGCs between 2012 and 2023 were included. The cohort was divided into the diagnosed and undiagnosed groups based on the preoperative diagnosis of MSGC determined by fine-needle aspiration cytology (FNAC) or core-needle biopsy. Clinicopathologic features, surgical strategies, and loco-regional control (LRC) were compared between the groups. RESULTS: A total of 122 patients were enrolled. Among those, 49 (40.2%) were diagnosed preoperatively, while 73 (59.8%) were undiagnosed. The undiagnosed group had a higher reliance on FNAC (93.2% vs 51.0%, P < .001) and higher proportions of low/intermediate-grade tumors (75% vs 26.5%, P < .001) and mucoepidermoid carcinoma (45.2% vs 18.4%, P < .001). These were verified as independent risk factors for preoperative undiagnosis in multivariate logistic regression analysis. The undiagnosed group was associated with delayed (60 vs 24 days, P < .001) and more limited surgical procedures, including lower frequency of near-total/total parotidectomy (23.3% vs 42.9%, P = .001) and elective neck dissection (26.5% vs 61.6%, P < .001), compared to the diagnosed group. Grade- and stage-matched analysis showed a trend towards worse LRC in the high-grade or advanced-stage undiagnosed MSGCs. CONCLUSIONS: Preoperatively undiagnosed MSGCs exhibit distinct clinicopathological characteristics, treatment strategies, and oncological outcomes compared to preoperatively diagnosed cases, highlighting the critical role of preoperative diagnosis in the management MSGCs.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Ahn D, Califano J, Kwak J, et al. Preoperatively Diagnosed Versus Undiagnosed Major Salivary Gland Cancer: Clinicopathological Characteristics, Treatment Strategies, and Oncological Outcomes. Otolaryngol Head Neck Surg. 2026. PMID: 42405878. doi:10.1002/ohn.70330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。